A preliminary analysis of the effect of long-term therapy with oral papaver ine has been made in 11 patients with chronic cerebral ischemia due to cerebral arteriosclerosis. The cases were classified as remote cerebral infarction (6 pa tients) or vertebrobasilar arterial insufficiency (5 patients). The patients received 225 mg or 450 mg daily, assigned in a double-blind manner. Most showed clinical improvement and improvement on the EEG. There was a statistically significant increase in regional cerebral blood flow in the vertebrobasilar arterial distribution, including the brain stem and cerebellar and posterior cerebral regions, particularly in the right hemisphere. Evidence appears to indicate that zones of severe remote cerebral infarction are refractory to pharmacologically induced vasodilation.
Get full access to this article
View all access options for this article.
References
1.
Jayne, H.W., Scheinberg, P., Rich, M., et al.: The effect of intravenous papaverine hydrochloride on cerebral circulation. J. Clin. Invest., 31: 111-114, 1952.
2.
Meyer, J.S., Teraura, T., Sakamoto, K., et al.: The effect of Pavibid (oral papaverine) on cerebral blood flow and metabolism in the monkey. Cardiovasc. Res. Center Bull. , 9: 105-108, 1971.
3.
Wang, H.S., Obrist, W.D.: Effect of oral papaverine on cerebral blood flow in normals: Evaluation by the Xenon133 inhalation method. Biol. Psychiatry, 11: 217-225, 1976.
4.
Meyer, J.S., Gotoh, F., Gilroy, J., et al.: Improvement in blood oxygenation and clinical improvement in patients with strokes treated with papaverine hydrochloride. J.A.M.A., 194: 957, 1965.
5.
McHenry, L.C. , Jr., Jaffe, M.E., Kawamura , J., et al.: Effect of papaverine on regional blood flow in focal vascular disease of the brain. N. Engl. J. Med., 282: 1167, 1970.
6.
Aizawa, T., Tazaki, Y., Gotoh, F.: Cerebral circulation in cerebrovascular disease. World Neurology , 2: 635, 1961.
7.
Naritomi, H. , Sakai, F., Meyer , J.S.: Pathogenesis of transient ischemic attacks within the vertebrobasilar arterial system. Arch. Neurol. , in press, 1978.
8.
Dunlop, E.: Chronic cerebrovascular insufficiency treated with papaverine. J. Am. Geriatr. Soc., 16: 343-349, 1968.
9.
Lee, B.Y., Sakamoto, H., Trainor, F., et al.: Comparison of soft gelatin capsule vs. sustained release formulation of papaverine HCL: Vasodilation and plasma levels. Int. J. Clin. Pharmacol., 16: 32-39, 1978.
10.
Arnold, J.D. , Baldridge, J., Riley , B., et al.: Papaverine hydrochloride: The evaluation of two new dosage forms. Int. J. Clin. Pharmacol., 15: 230-233, 1977.
11.
Mallett, B.L. , Veal, N.: The measurement of regional cerebral clearance rates in man using Xenon133 inhalation and extracranial recording . Clin. Sci., 29: 179, 1965.
12.
Obrist, W.D. , Thompson, H.K., Wang , H.F., et al.: Regional cerebral blood flow estimated by Xenon133 inhalation. Stroke , 6: 245-256, 1975.
13.
Meyer, J.S. , Ishihara, N., Deshmukh , V.D. et al.: An improved method for non-invasive measurement of regional cerebral blood flow and blood volume by 133Xe inhalation. Description of the method and normal values obtained in healthy volunteers . Stroke, in press, 1978.
14.
Sakai, F., Meyer, J.S., Karacan, I., et al.: Regional cerebral blood flow during sleep and wakefulness in normal volunteers and patients with narcolepsy. Submitted for publication.
15.
Blauenstein, U.W., Halsey, H.J., Wilson , E.M. et al.: The 133Xenon inhalation method. Analysis of reproducibility. In M. Harper , B. Jennett, D. Miller, et al.; Blood Flow and Metabolism in the Brain . Edinburg: Churchill, Livingstone , 1975, pp. 8, 19-8.22.
16.
Naritomi, H. , Meyer, J.S., Deshmukh, V.D., et al.: Noninvasive measurement of regional cerebral blood flow in TIAs and stroke due to carotid and vertebrobasilar disease. In Cerebral Function, Metabolism and Circulation . Copenhagen , Munksgaard, 1977, pp. 476-477.
17.
Meyer, J.S. , Sakai, F., Naritomi , H., et al.: Normal and abnormal patterns of cerebrovascular reserve tested by 133Xe inhalation. Arch. Neurol., in press, 1978.
18.
Roberts, J.C. , Jr., Moses, C., Wilkins , R.H.: Autopsy studies in atherosclerosis. I. Distribution and severity of atherosclerosis in patients dying without morphologic evidence of arthersclerotic catastrophe. Circulation, 20: 511-519, 1959.
19.
Blumenthal, H.T., Handler, F.P., Blanche , J.O.: The histogenesis of arteriosclerosis of the larger cerebral arteries, with an analysis of the importance of mechanical factors. Am. J. Med., 17: 337-347, 1954.
20.
Naritomi, H. , Meyer, J.S., Sakai, F., et al.: Effects of advancing age on regional cerebral blood flow in normals versus subjects with risk factors for atherothrombotic stroke. Submitted for publication.
